We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$51.8B
AUM Growth
+$2.19B
Cap. Flow
-$1.04B
Cap. Flow %
-2.01%
Top 10 Hldgs %
17.67%
Holding
2,975
New
68
Increased
781
Reduced
1,984
Closed
53

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$102M
2
XL
XL Group Ltd.
XL
+$28.4M
3
MSFT icon
Microsoft
MSFT
+$26.9M
4
CSCO icon
Cisco
CSCO
+$24.2M
5
GGP
GGP Inc.
GGP
+$24M

Sector Composition

Rank Sector Weight
1 Technology 18.16%
2 Financials 15.87%
3 Healthcare 13.94%
4 Consumer Discretionary 10.36%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NETI
2351
DELISTED
Eneti Inc.
NETI
$416K ﹤0.01%
6,175
+49
+0.8% +$3.19K
KDNY
2352
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$416K ﹤0.01%
11,317
-830
-7% -$26.6K
FBNK
2353
DELISTED
First Connecticut Bancorp, Inc
FBNK
$415K ﹤0.01%
14,039
-55
-0.4% -$1.71K
LXRX icon
2354
Lexicon Pharmaceuticals
LXRX
$1.05B
$414K ﹤0.01%
38,817
-2,780
-7% -$31.9K
SEI
2355
Solaris Energy Infrastructure
SEI
$3.49B
$414K ﹤0.01%
21,935
-1,388
-6% -$22.3K
NXEO
2356
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$413K ﹤0.01%
33,694
+204
+0.6% +$2.04K
VSTM icon
2357
Verastem
VSTM
$519M
$412K ﹤0.01%
4,731
+564
+14% +$56.1K
PDLI
2358
DELISTED
PDL BioPharma, Inc.
PDLI
$411K ﹤0.01%
156,246
-1,350
-0.9% -$3.31K
CCNE icon
2359
CNB Financial Corp
CCNE
$1.04B
$410K ﹤0.01%
14,219
-50
-0.4% -$1.54K
INO icon
2360
Inovio Pharmaceuticals
INO
$69.6M
$410K ﹤0.01%
6,139
-438
-7% -$24.4K
ANCX
2361
DELISTED
Access National Corp
ANCX
$410K ﹤0.01%
15,134
+50
+0.3% +$1.4K
KURA icon
2362
Kura Oncology
KURA
$824M
$408K ﹤0.01%
23,337
-310
-1% -$5.94K
LCI
2363
DELISTED
Lannett Company, Inc.
LCI
$407K ﹤0.01%
21,399
+1,747
+9% +$66.6K
ADMS
2364
DELISTED
Adamas Pharmaceuticals
ADMS
$406K ﹤0.01%
20,267
-625
-3% -$14.7K
EEX
2365
DELISTED
Emerald Holding
EEX
$405K ﹤0.01%
24,553
+30
+0.1% +$521
AKCA
2366
DELISTED
Akcea Therapeutics Inc
AKCA
$404K ﹤0.01%
11,542
-704
-6% -$21.3K
WMC
2367
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$403K ﹤0.01%
4,020
+36
+0.9% +$3.9K
AKBA icon
2368
Akebia Therapeutics
AKBA
$264M
$399K ﹤0.01%
45,234
-2,413
-5% -$21.6K
BZH icon
2369
Beazer Homes USA
BZH
$915M
$398K ﹤0.01%
37,885
BSRR icon
2370
Sierra Bancorp
BSRR
$530M
$397K ﹤0.01%
13,723
+132
+1% +$3.89K
CTRN icon
2371
Citi Trends
CTRN
$600M
$396K ﹤0.01%
13,779
+152
+1% +$4.49K
VTI icon
2372
Vanguard Morningstar Total Stock Market ETF
VTI
$680B
$396K ﹤0.01%
+2,645
New +$389K
OPCH icon
2373
Option Care Health
OPCH
$3.54B
$394K ﹤0.01%
31,802
+82
+0.3% +$960
COLL icon
2374
Collegium Pharmaceutical
COLL
$944M
$391K ﹤0.01%
26,541
-1,800
-6% -$31.9K
NINE
2375
DELISTED
Nine Energy Service
NINE
$391K ﹤0.01%
12,795
+5,275
+70% +$160K

Similar funds

RhumbLine Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, RhumbLine Advisers held 2,975 positions worth $51.8B, up 4.4% from $49.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 4.1%. RhumbLine Advisers opened 68 new positions and exited 53, leaving the 2,975-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2018 buy was iShares TIPS Bond ETF: 312,303 shares worth $34.5M.
  • RhumbLine Advisers added most to Williams Companies in Q3 2018, an estimated $16.4M increase.
  • RhumbLine Advisers's biggest Q3 2018 reduction was Apple, cutting an estimated $102M.
  • RhumbLine Advisers fully exited XL Group Ltd. in Q3 2018, selling an estimated $28.4M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $51.8B portfolio in Q3 2018.
  • RhumbLine Advisers opened 68 new positions and closed 53 in Q3 2018.
  • RhumbLine Advisers's portfolio value rose 4.4% quarter-over-quarter to $51.8B.

Based on RhumbLine Advisers's 13F filing for Q3 2018, filed 7 Nov 2018.